GL1X · GenesisL1 explorer

Research workbench

Crystal structure of V30M mutant human transthyretin complexed with caffeic acid ethyl ester

Analyse Crystal structure of V30M mutant human transthyretin complexed with caffeic… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4PWG
Type
protein
Length
231 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
0XR, CA
Pockets
2 · best druggability 0.36

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1165% helix, 53% strandP02766
BTransthyretinprotein1156% helix, 53% strandP02766

Ligands and binding sites

  • 0XR · ethyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate · ligand · 2 copies · chains A, B
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1920.360.7517empty
2560.290.7514empty

Interfaces

1 interface between chains.

  • A–B · 923 Ų buried · 22 hydrogen bonds · protein-protein

Compared structures

  • 4PWG · Crystal structure of V30M mutant human transthyretin complexed with caffeic acid ethyl… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.